STACY KONYAR: Open Payments
NPI 1972806404 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,579 in 132 payments from 21 companies in 2025. Trend: 2023 $6,260 · 2024 $2,322 · 2025 $2,579
Food & beverage: $2,579
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $643 |
| Novo Nordisk Inc | 21 | $464 |
| PFIZER INC. | 21 | $313 |
| Axsome Therapeutics, Inc. | 10 | $209 |
| AstraZeneca Pharmaceuticals LP | 9 | $184 |
| Astellas Pharma US Inc | 6 | $135 |
| Lilly USA, LLC | 6 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| HARMONY BIOSCIENCES LLC | 2 | $58 |
| Abbott Laboratories | 3 | $57 |
Products named: NURTEC ODT, VRAYLAR, Auvelity, UBRELVY, QULIPTA, Ozempic, Veozah, Wegovy.
Industry payments across VA — which companies pay providers there.
